148 related articles for article (PubMed ID: 2203825)
1. Vasoactive intestinal peptide in human nasal mucosa.
Baraniuk JN; Lundgren JD; Okayama M; Mullol J; Merida M; Shelhamer JH; Kaliner MA
J Clin Invest; 1990 Sep; 86(3):825-31. PubMed ID: 2203825
[TBL] [Abstract][Full Text] [Related]
2. Gastrin-releasing peptide in human nasal mucosa.
Baraniuk JN; Lundgren JD; Goff J; Peden D; Merida M; Shelhamer J; Kaliner M
J Clin Invest; 1990 Apr; 85(4):998-1005. PubMed ID: 2318984
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y (NPY) in human nasal mucosa.
Baraniuk JN; Castellino S; Lundgren JD; Goff J; Mullol J; Merida M; Shelhamer JH; Kaliner MA
Am J Respir Cell Mol Biol; 1990 Aug; 3(2):165-73. PubMed ID: 2378751
[TBL] [Abstract][Full Text] [Related]
4. Substance P and neurokinin A in human nasal mucosa.
Baraniuk JN; Lundgren JD; Okayama M; Goff J; Mullol J; Merida M; Shelhamer JH; Kaliner MA
Am J Respir Cell Mol Biol; 1991 Mar; 4(3):228-36. PubMed ID: 1705809
[TBL] [Abstract][Full Text] [Related]
5. Inhibition by vasoactive intestinal peptide of glycoconjugate and lysozyme secretion by human airways in vitro.
Coles SJ; Said SI; Reid LM
Am Rev Respir Dis; 1981 Nov; 124(5):531-6. PubMed ID: 7305106
[TBL] [Abstract][Full Text] [Related]
6. The effects of neuropeptides on mucous glycoprotein secretion from human nasal mucosa in vitro.
Mullol J; Rieves RD; Baraniuk JN; Lundgren JD; Mérida M; Hausfeld JH; Shelhamer JH; Kaliner MA
Neuropeptides; 1992 Apr; 21(4):231-8. PubMed ID: 1381497
[TBL] [Abstract][Full Text] [Related]
7. Distribution of vasoactive intestinal polypeptide immunoreactive nerve fiber in the rat nasal mucosa.
Katahashi T; Kanda T; Hanazawa T; Konno A; Tatsuoka H
Auris Nasus Larynx; 1997; 24(1):59-64. PubMed ID: 9148730
[TBL] [Abstract][Full Text] [Related]
8. [Current immunohistochemical results of localization of vasoactive intestinal polypeptide (VIP) in nasal mucosa of the human].
Riederer A; Knipping S; Fischer A; Unger J
Laryngorhinootologie; 1995 Oct; 74(10):611-4. PubMed ID: 8672200
[TBL] [Abstract][Full Text] [Related]
9. Endothelin in human nasal mucosa.
Mullol J; Chowdhury BA; White MV; Ohkubo K; Rieves RD; Baraniuk J; Hausfeld JN; Shelhamer JH; Kaliner MA
Am J Respir Cell Mol Biol; 1993 Apr; 8(4):393-402. PubMed ID: 8476633
[TBL] [Abstract][Full Text] [Related]
10. Bradykinin and respiratory mucous membranes. Analysis of bradykinin binding site distribution and secretory responses in vitro and in vivo.
Baraniuk JN; Lundgren JD; Mizoguchi H; Peden D; Gawin A; Merida M; Shelhamer JH; Kaliner MA
Am Rev Respir Dis; 1990 Mar; 141(3):706-14. PubMed ID: 2178531
[TBL] [Abstract][Full Text] [Related]
11. Calcitonin gene-related peptide in human nasal mucosa.
Baraniuk JN; Lundgren JD; Goff J; Mullol J; Castellino S; Merida M; Shelhamer JH; Kaliner MA
Am J Physiol; 1990 Feb; 258(2 Pt 1):L81-8. PubMed ID: 2305901
[TBL] [Abstract][Full Text] [Related]
12. Vasoactive intestinal peptide and intraocular pressure: adenylate cyclase activation and binding sites for vasoactive intestinal peptide in membranes of ocular ciliary processes.
Mittag TW; Tormay A; Podos SM
J Pharmacol Exp Ther; 1987 Apr; 241(1):230-5. PubMed ID: 3033201
[TBL] [Abstract][Full Text] [Related]
13. Vasoactive intestinal polypeptide and cholinergic mechanisms in cat nasal mucosa: studies on choline acetyltransferase and release of vasoactive intestinal polypeptide.
Lundberg JM; Anggård A; Emson P; Fahrenkrug J; Hökfelt T
Proc Natl Acad Sci U S A; 1981 Aug; 78(8):5255-9. PubMed ID: 6946470
[TBL] [Abstract][Full Text] [Related]
14. VIP augments cholinergic-induced glycoconjugate secretion in tracheal submucosal glands.
Shimura S; Sasaki T; Ikeda K; Sasaki H; Takishima T
J Appl Physiol (1985); 1988 Dec; 65(6):2537-44. PubMed ID: 2851006
[TBL] [Abstract][Full Text] [Related]
15. Effect of vasoactive intestinal peptide on gastric adenocarcinoma.
Li GH; Qian W; Song GQ; Hou XH
J Gastroenterol Hepatol; 2007 Aug; 22(8):1328-35. PubMed ID: 17559364
[TBL] [Abstract][Full Text] [Related]
16. Vasoactive intestinal polypeptide: a transmitter in submucous neurons mediating secretion in guinea pig distal colon.
Reddix R; Kuhawara A; Wallace L; Cooke HJ
J Pharmacol Exp Ther; 1994 Jun; 269(3):1124-9. PubMed ID: 7912276
[TBL] [Abstract][Full Text] [Related]
17. Peptide containing nerves in the nasal mucosa.
Uddman R; Malm L; Sundler F
Rhinology; 1981 Jun; 19(2):75-9. PubMed ID: 6166979
[TBL] [Abstract][Full Text] [Related]
18. VIP potentiates cholinergic effects on the mucociliary system in the maxillary sinus.
Lindberg S; Cervin A; Mercke U; Uddman R
Otolaryngol Head Neck Surg; 1988 Oct; 99(4):401-7. PubMed ID: 3148890
[TBL] [Abstract][Full Text] [Related]
19. The distribution of nerve fibres immunoreactive for vasoactive intestinal peptide, calcitonin gene-related peptide, substance P and dopamine beta-hydroxylase in the normal equine larynx.
Corcoran BM; Jarvis S; Hahn CN; Mayhew IG
Res Vet Sci; 1999 Dec; 67(3):251-9. PubMed ID: 10607505
[TBL] [Abstract][Full Text] [Related]
20. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells.
Jiang S; Kopras E; McMichael M; Bell RH; Ulrich CD
Cancer Res; 1997 Apr; 57(8):1475-80. PubMed ID: 9108448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
